PubMed=2556716; DOI=10.1073/pnas.86.23.9524; PMCID=PMC298529
Glaser R., Zhang H.-Y., Yao K.-T., Zhu H.-C., Wang F.-X., Li G.-Y., Wen D.-S., Li Y.-P.
Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
Proc. Natl. Acad. Sci. U.S.A. 86:9524-9528(1989)

PubMed=12097280
Chang J.-Y., Liu J.-F., Juang S.-H., Liu T.-W., Chen L.-T.
Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.
Cancer Res. 62:3716-3721(2002)

PubMed=24991015; DOI=10.1128/JVI.01457-14; PMCID=PMC4178894
Strong M.J., Baddoo M., Nanbo A., Xu M., Puetter A., Lin Z.
Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes.
J. Virol. 88:10696-10704(2014)

PubMed=25877200; DOI=10.1038/nature14397
Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.
A resource for cell line authentication, annotation and quality control.
Nature 520:307-311(2015)

CLPUB00484
Xu Z.-H., Sun W.-W., Hang J.-B., Gao B.-L., Hu J.-A.
RNA-seq identified a novel functional MET fusion in head and neck cancer 5-8F cell line.
Int. J. Clin. Exp. Pathol. 9:8308-8317(2016)